# Positive Effects of (+)-Epicatechin on Traumatic Spinal Cord Injury Recovery

**Authors:** Cristian Gonzalez-Ruiz, Rodrigo Mondragón-Lozano, Hermelinda Salgado-Ceballos, Francisco Villarreal, Yuridia Martínez-Meza, Eduardo Meaney, Nayelli Nájera, Guillermo Ceballos

PMC · DOI: 10.3390/biom15060869 · 2025-06-14

## TL;DR

This study shows that the natural compound (+)-epicatechin may help protect against spinal cord injury and improve recovery.

## Contribution

The study introduces (+)-epicatechin as a potential new treatment for traumatic spinal cord injury.

## Key findings

- EC significantly protected against spinal cord injury in a rat model.
- Key protein markers showed no changes, indicating reduced damage progression.
- Improved movement was observed in treated rats.

## Abstract

Neurological damage from traumatic spinal cord injury (SCI) results in a grade of disability ranging from mild to severe motor and sensory dysfunction. It occurs more frequently in men of productive age. Treatment essentially consists of anti-inflammatories and rehabilitation. Other treatments are only partially effective, and inadequate treatment and secondary conditions often cause premature mortality. The search for pharmacological approaches is a continuous effort. This study aimed to assess the effects of a natural compound on spinal cord injury (SCI) as an alternative damage prevention maneuver. We evaluated the protective effects of the flavanol (+)-epicatechin (EC) in a rat model of moderate trauma-induced SCI on protein markers of damage events. The results showed that EC induced significant protection against SCI. No changes were found in angiopoietin-1, beclin-1, myelin basic protein, glial fibrillary acidic protein, neurofilament heavy polypeptide, and neuronal nuclear antigen after the injury, suggesting that damage progression was impeded. The reduction in damage translates into better movement. The results suggest that (+)-epicatechin may be a suitable alternative for treating SCI.

## Linked entities

- **Proteins:** BECN1 (beclin 1)
- **Chemicals:** (+)-epicatechin (PubChem CID 1203)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** MBP (myelin basic protein) [NCBI Gene 4155], NEFH (neurofilament heavy chain) [NCBI Gene 4744] {aka CMT2CC, NFH}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, ANGPT1 (angiopoietin 1) [NCBI Gene 284] {aka AGP1, AGPT, AGPT-1, ANG1, HAE5}
- **Diseases:** Neurological damage (MESH:D020196), SCI (MESH:D013119), motor and sensory dysfunction (MESH:C536988), disability (MESH:D009069), trauma (MESH:D014947)
- **Chemicals:** flavanol (-), (+)-Epicatechin (MESH:D002392)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12190840/full.md

---
Source: https://tomesphere.com/paper/PMC12190840